Off-Label Dapagliflozin After Atrial Fibrillation Ablation: A Reasonable Intervention or Overstretching the Evidence?

Circulation 2026

View at publisher

Authors: Yang Chen, Sean D. Pokorney, Gregory Y.H. Lip

DOI: 10.1161/circulationaha.125.078518

Cited by: 1

References: 12

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Diabetes Treatment and Management Cardiac Arrhythmias and Treatments

References 12